D-2-Hydroxyglutaric acid



Compound IDCDAMM02314
Common nameD-2-Hydroxyglutaric acid
IUPAC name2-hydroxypentanedioic acid
Molecular formulaC5H8O5

Experimental data

Retention time14.46
Adduct[M+H]+
Actual mz149.044
Theoretical mz149.044
Error3.19
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.8112

Identifiers and class information

Inchi keyHWXBTNAVRSUOJR-YEQUQEJONA-N
SmilesO=C(O)CCC(O)C(=O)O
SuperclassOrganic acids and derivatives
ClassHydroxy acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)2
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)2
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)148.115
Computed dipole moment(dipole)7.23
Total solvent accessible surface area (SASA)336.224
Hydrophobic component of SASA (FOSA)83.572
Hydrophilic component of SASA (FISA)252.652
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)509.032
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)5.7
Free energy of solvation of dipole (dip^2/V)0.102684
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0293634
Globularity descriptor (glob)0.916993
Predicted polarizability in cubic angstroms (QPpolrz)11.007
Predicted hexadecane/gas partition coefficient (QPlogPC16)5.4
Predicted octanol/gas partition coefficient (QPlogPoct)12.204
Predicted water/gas partition coefficient (QPlogPw)11.152
Predicted octanol/water partition coefficient (QPlogPo/w)-0.391
Predicted aqueous solubility (QPlogS)-0.608
Conformation-independent predicted aqueous solubility (CIQPlogS)-0.592
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)0.74
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)2.554
Predicted brain/blood partition coefficient (QPlogBB)-1.741
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1.261
Predicted skin permeability, log Kp (QPlogKp)-5.696
PM3 calculated ionization potential (IP(ev))10.974
PM3 calculated electron affinity (EA(eV))-0.229
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)-1.244
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)31.942
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)121.891
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O75899GABBR2GABA-B receptorT42446SEA
P48066SLC6A11GABA transporter 3T38200SEA
O75899GABBR2GABA-B receptorT42446SEA
O00222GRM8Metabotropic glutamate receptor 8T77548SEA
Q4U2R8SLC22A6Solute carrier family 22 member 6 (by homology)T70680SEA
P78352DLG4Disks large homolog 4T04507SEA
O15303GRM6Metabotropic glutamate receptor 6T55956SEA
Q6B0I6KDM4DLysine-specific demethylase 4DT17036SEA
Q07075ENPEPAminopeptidase AT31956SEA
P41229KDM5CLysine-specific demethylase 5CT85540SEA
Q9Y2K7KDM2ALysine-specific demethylase 2AT71949SEA
Q9Y3Q0NAALAD2NAALADase IIT70036SEA
Q92820GGHGamma-glutamyl hydrolaseT71646SEA
P53396ACLYATP-citrate synthaseT52189SwissTargetPrediction
Q9UPP1PHF8Histone lysine demethylase PHF8T00933SEA
Q04609FOLH1Glutamate carboxypeptidase IIT97071SEA
Q4U2R8SLC22A6Solute carrier family 22 member 6 (by homology)T70680SEA
Q9UN88GABRQGABA(A) receptor thetaT15161SEA
O60603TLR2Toll-like receptor 2T82078SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T42446DI0117Depression[ICD-11: 6A70-6A7Z]O75899GABBR2
T42446DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]O75899GABBR2
T42446DI0275Multiple sclerosis[ICD-11: 8A40]O75899GABBR2
T42446DI0290Narcolepsy[ICD-11: 7A20]O75899GABBR2
T38200DI0207Indeterminate colitis[ICD-11: DD72]P48066SLC6A11
T42446DI0117Depression[ICD-11: 6A70-6A7Z]O75899GABBR2
T42446DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]O75899GABBR2
T42446DI0275Multiple sclerosis[ICD-11: 8A40]O75899GABBR2
T42446DI0290Narcolepsy[ICD-11: 7A20]O75899GABBR2
T70680DI0167Gout[ICD-11: FA25]Q4U2R8SLC22A6
T70680DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]Q4U2R8SLC22A6
T70680DI0310Ocular disease[ICD-11: N.A.]Q4U2R8SLC22A6
T04507DI0073Cerebral ischaemia[ICD-11: 8B1Z]P78352DLG4
T04507DI0219Ischaemic/haemorrhagic stroke[ICD-11: 8B20]P78352DLG4
T31956DI0190Hypertension[ICD-11: BA00-BA04]Q07075ENPEP
T52189DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P53396ACLY
T97071DI0122Diagnostic imaging[ICD-11: N.A.]Q04609FOLH1
T97071DI0346Prostate cancer[ICD-11: 2C82]Q04609FOLH1
T70680DI0167Gout[ICD-11: FA25]Q4U2R8SLC22A6
T70680DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]Q4U2R8SLC22A6
T70680DI0310Ocular disease[ICD-11: N.A.]Q4U2R8SLC22A6
T82078DI0346Prostate cancer[ICD-11: 2C82]O60603TLR2

Copyright © 2025